Assignee
NEUFORM PHARMACEUTICALS INC
US·2 granted patents·1 pending application·0 citations·filing 2016–2017
Top patents by PatentIndex Score
3 records- 0132US9968606B2Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereofNEUFORM PHARMACEUTICALS INC·Filed 2017·Granted May 15, 2018·0 cites·29 claims
- 0230US9688659B2Deuterated compounds for treating hematologic malignancies, and compositions and methods thereofNEUFORM PHARMACEUTICALS INC·Filed 2016·Granted Jun 27, 2017·0 cites·14 claims
- 0330US2020330444A1Deuterated compounds for treating pain and related diseases and conditions, and compositions and methods thereofNEUFORM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEUFORM PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →